文献速递胸部肿瘤支持与姑息治疗

大麻使用、肺功能与肺癌易感性:孟德尔随机化研究

Cannabis Use, Pulmonary Function, and Lung Cancer Susceptibility: A Mendelian Randomization Study.
PubMed 文献 · J Thorac Oncol · 2021-04-20

该研究采用孟德尔随机化方法,利用终身大麻使用和 大麻使用障碍的遗传工具变量,评估其对肺功能与肺癌的独立效应。结果显示终身大麻使用的遗传易感性与鳞状细胞癌风险升高相关(OR=1.22,95%CI=1.07-1.39,P=0.003,q=0.025),未发现与肺功能或其他肺癌亚型的显著关联。

要点

  • 终身大麻使用遗传易感性与鳞状细胞癌风险升高相关(OR=1.22)。
  • 该关联在多种稳健性分析和对照分析中未提示偏倚。
  • 需三角验证孟德尔随机化与观察性研究以确认因果性。

核心结论

  • 遗传易感的大麻使用与鳞状细胞癌风险存在潜在因果关联(OR=1.22,95%CI=1.07-1.39,P=0.003,q=0.025)。

研究设计与样本

  • 采用孟德尔随机化设计,以4个SNP作为终身大麻使用的工具变量(GWAS样本184,765人)。
  • 以7个SNP作为大麻使用障碍的工具变量(17,068例病例和357,219例对照)。
  • 肺功能GWAS纳入79,055人,肺癌GWAS纳入29,266例病例和56,450例对照。

主要发现

  • 终身大麻使用遗传易感性与鳞状细胞癌风险升高相关(OR=1.22,95%CI=1.07-1.39,P=0.003,q=0.025)。
  • 多效性稳健方法和阳性/阴性对照分析未提示主要分析存在偏倚。

临床怎么用

  • 提示临床医生在评估肺癌风险时应考虑患者大麻使用史,尤其鳞状细胞癌风险。

局限性

  • 需三角验证孟德尔随机化与观察性研究并解决正交偏倚来源以确认发现。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Because of widespread use, understanding the pulmonary effects of cannabis use is important; but its role independent from tobacco smoking is yet to be elucidated. We used Mendelian randomization (MR) to assess the effect of genetic liability to lifetime cannabis use and cannabis use disorder on pulmonary function and lung cancer. METHODS: We used four single nucleotide polymorphisms associated with lifetime cannabis use (p value <5 × 10-8) from a genome-wide association study (GWAS) of 184,765 individuals of European descent from the International Cannabis Consortium, 23andme, and U.K. Biobank as instrumental variables. Seven single nucleotide polymorphisms (p value <5 × 10-8) were selected as instruments for cannabis use disorder from a GWAS meta-analysis of 17,068 European ancestry cases and 357,219 controls of European descent from Psychiatric Genomics Consortium Substance Use Disorders working group, Lundbeck Foundation Initiative for Integrative PsychiatricResearch, and deCode. To assess lung function, GWAS included 79,055 study participants of the SpiroMeta Consortium, and for lung cancer GWAS from the International Lung Cancer Consortium contained 29,266 cases and 56,450 controls. RESULTS: MR revealed that genetic liability to lifetime cannabis use was associated with increased risk of squamous cell carcinoma (OR = 1.22, 95%, confidence interval = 1.07-1.39, p value = 0.003, q value = 0.025). Pleiotropy-robust methods and positive and negative control analyses did not indicate bias in the primary analysis. CONCLUSIONS: The findings of this MR analysis suggest evidence for a potential causal association between genetic liability for cannabis use and the risk of squamous cell carcinoma. Triangulating MR and observational studies and addressing orthogonal sources of bias are necessary to confirm this finding.

来源:J Thorac Oncol,查看原文。版权归原作者所有。

引用

  1. Baumeister SE, Baurecht H, Nolde M, et al. Cannabis Use, Pulmonary Function, and Lung Cancer Susceptibility: A Mendelian Randomization Study. J Thorac Oncol. 2021. PMID: 33852959. doi:10.1016/j.jtho.2021.03.025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。